Organon & Co. logo

Organon & Co. (US68622V1061)

Market Closed
21 Aug, 20:00
XSTU XSTU
11. 75
+0.01
+0.0852%
- Market Cap
5.74 P/E Ratio
- Div Yield
36 Volume
4.1 Eps
11.74
Previous Close
Add Transaction
Day Range
11.5 11.75
Year Range
4.96 11.93
Want to track US68622V1061 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

US68622V1061 closed today higher at €11.75, an increase of 0.0852% from yesterday's close, completing a monthly increase of 0.2988% or €0.04. Over the past 12 months, US68622V1061 stock gained 94.5364%.
US68622V1061 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

US68622V1061 Chart

Organon & Co. (US68622V1061) FAQ

What is the stock price today?

The current price is €11.75.

On which exchange is it traded?

Organon & Co. is listed on XSTU.

What is its stock symbol?

The ticker symbol is US68622V1061.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Organon & Co. ever had a stock split?

No, there has never been a stock split.

Organon & Co. Profile

Pharmaceuticals Industry
Healthcare Sector
Joseph T. Morrissey Jr. CEO
XSTU Exchange
- ISIN
US Country
10,000 Employees
- Last Dividend
- Last Split
2 Jun 2021 IPO Date

Overview

Organon & Co. is a healthcare company focused on innovating and providing a range of health solutions specifically tailored towards women's health needs both in the United States and globally. The company's diverse product offering encompasses a variety of prescription therapies and medical devices. Founded in 2020 and headquartered in Jersey City, New Jersey, Organon & Co. has quickly positioned itself as a key player in women's health, extending its reach through a broad spectrum of contraception and fertility treatments, biosimilars, and other healthcare solutions. Their mission extends to addressing critical areas such as cardiovascular health, respiratory conditions, dermatology, bone health, and non-opioid pain management, catering to a wide demographic. Through its commitment to health innovation, Organon & Co. markets its products to a vast network of stakeholders including drug wholesalers, retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions.

Products and Services

  • Nexplanon: A long-acting reversible contraceptive that offers an effective birth control option.
  • NuvaRing: A monthly vaginal ring designed for convenient contraception.
  • Cerazette: An oral contraceptive pill that helps prevent pregnancy.
  • Marvelon: A daily pill that combines progestin and estrogen to prevent pregnancy.
  • Follistim AQ: Utilized in assisted reproduction to stimulate the development of multiple ovarian follicles.
  • Elonva: An ovarian follicle stimulant for use in assisted reproductive technologies.
  • Ganirelix Acetate Injection: An injectable solution that acts as an antagonist in fertility treatments.
  • Jada: A solution for treating abnormal postpartum uterine bleeding or hemorrhage.
  • Biosimilars Portfolio: Includes immunology products like Brenzys, Renflexis, and Hadlima, along with two oncology products, Ontruzant and Aybintio, offering alternatives to existing biologic medicines.
  • Cholesterol-modifying Medicines: Managed under brands such as Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor to help control cholesterol levels.
  • Cozaar and Hyzaar: Prescribed for the treatment of hypertension.
  • Respiratory Products: Include treatments for asthma under the Singulair, Dulera, Zenhale, and Asmanex brands.
  • Seasonal Allergic Rhinitis Treatments: Products like Singulair, Nasonex, Clarinex, and Aerius are aimed at treating seasonal allergies.
  • Dermatology Products: Including treatments for skin conditions under the Diprosone and Elocon brands.
  • Bone Health Portfolio: Features the Fosamax brand for bone health management.
  • Non-opioid Pain Management Products: Offering solutions like Arcoxia, Diprospan, and Celestone for pain management without the use of opioids.
  • Proscar: Used in the treatment of symptomatic benign prostatic hyperplasia.
  • Propecia: A treatment solution for male pattern hair loss.

Contact Information

Address: 30 Hudson Street
Phone: 551 430 6000